MUZAFFAR H QAZILBASH to Antigens, Differentiation, Myelomonocytic
This is a "connection" page, showing publications MUZAFFAR H QAZILBASH has written about Antigens, Differentiation, Myelomonocytic.
Connection Strength
0.018
-
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia. 2008 Feb; 22(2):258-64.
Score: 0.018